Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » GenMark Diagnostics Begins Shipping SARS-CoV-2 Assay While Interest in BCID Panel Grows

GenMark Diagnostics Begins Shipping SARS-CoV-2 Assay While Interest in BCID Panel Grows

Mar 03, 2020
|
Leo O'Connor
Premium

NEW YORK – As GenMark Diagnostics tries to gain traction in the infectious disease testing space, it said on Monday it had joined the growing number of firms that are developing a test for the novel coronavirus test.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

To Keep Up

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

On the Rise in the City

The New York Times reports that a new viral variant of concern has been identified in New York City.

Nature Studies Present Single-Cell Map of Cell Cycle, Approach Identifies Cancer Treatment Resistance Pathways, More

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

What's Popular?

In Business News

  1. 10x Genomics Acquires Denmark's Tetramer Shop

  2. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  3. Miroculus Raises $45M in Extended Series B Financing

  4. Guardant Health Q4 Revenues Up 25 Percent

  5. Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.